JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3251
Innoviva
INVA
$1.48B
| $4.93M | ﹤0.01% |
284,386
-293,857
| -51% | -$5.64M |
2016 Q4
32 quarters
|
|
3252
PUT
FIVE9
FIVN
$2.57B
| $4.93M | ﹤0.01% |
121,300
| – | – |
2023 Q2
6 quarters
|
|
3253
Lindsay Corp
LNN
$1.16B
| $4.93M | ﹤0.01% |
41,640
+31,351
| +305% | +$3.89M |
2013 Q2
46 quarters
|
|
3254
Cartesian Therapeutics
RNAC
$223M
| $4.92M | ﹤0.01% |
274,740
-34,278
| -11% | -$694K |
2020 Q2
18 quarters
|
|
3255
EVgo
EVGO
$196M
| $4.92M | ﹤0.01% |
1,213,688
+586,108
| +93% | +$3.73M |
2021 Q4
12 quarters
|
|
3256
Utah Medical Products
UTMD
$235M
| $4.9M | ﹤0.01% |
79,703
+10,292
| +15% | +$665K |
2015 Q3
37 quarters
|
|
3257
PUT
Skyworks Solutions
SWKS
$12.8B
| $4.9M | ﹤0.01% |
55,200
-17,900
| -24% | -$1.63M |
2021 Q3
13 quarters
|
|
3258
CALL
ZTO Express
ZTO
$14.6B
| $4.89M | ﹤0.01% |
250,000
| – | – |
2023 Q3
5 quarters
|
|
3259
Veeco
VECO
$3.51B
| $4.89M | ﹤0.01% |
182,299
-94,069
| -34% | -$2.73M |
2016 Q3
33 quarters
|
|
3260
CALL
Enphase Energy
ENPH
$4.42B
| $4.88M | ﹤0.01% |
71,100
| – | – |
2023 Q2
6 quarters
|
|
3261
Coursera
COUR
$1.33B
| $4.88M | ﹤0.01% |
574,116
+93,959
| +20% | +$726K |
2021 Q1
15 quarters
|
|
3262
Middlesex Water
MSEX
$1.01B
| $4.87M | ﹤0.01% |
92,560
+60,337
| +187% | +$3.79M |
2015 Q4
36 quarters
|
|
3263
CALL
PPG Industries
PPG
$23.4B
| $4.86M | ﹤0.01% |
40,700
+15,700
| +63% | +$1.96M |
2023 Q2
6 quarters
|
|
3264
CALL
Fox Class A
FOXA
$26.3B
| $4.86M | ﹤0.01% |
100,000
| – | – |
2024 Q3
1 quarter
|
|
|
3265
PUT
Fox Class A
FOXA
$26.3B
| $4.86M | ﹤0.01% |
100,000
| – | – |
2024 Q3
1 quarter
|
|
3266
iShares US Transportation ETF
IYT
$2.07B
| $4.86M | ﹤0.01% |
71,880
+8,273
| +13% | +$585K |
2013 Q2
46 quarters
|
|
|
RDFN
3267
DELISTED
Redfin
RDFN
| $4.86M | ﹤0.01% |
616,923
+290,145
| +89% | +$2.81M |
2017 Q3
29 quarters
|
|
3268
CG Oncology
CGON
$5.97B
| $4.84M | ﹤0.01% |
168,866
+137,795
| +443% | +$4.71M |
2024 Q1
3 quarters
|
|
|
ZEUS
3269
DELISTED
Olympic Steel
ZEUS
| $4.84M | ﹤0.01% |
147,533
-66,960
| -31% | -$2.6M |
2016 Q1
35 quarters
|
|
|
GOOD
3270
Gladstone Commercial Corp
GOOD
$626M
| $4.83M | ﹤0.01% |
297,473
+116,355
| +64% | +$1.93M |
2013 Q3
45 quarters
|
|
3271
BW LPG
BWLP
$3.89B
| $4.83M | ﹤0.01% |
424,876
-1,002,600
| -70% | -$12.9M |
2024 Q2
2 quarters
|
|
3272
WisdomTree US High Dividend Fund
DHS
$1.55B
| $4.82M | ﹤0.01% |
51,622
+12,176
| +31% | +$1.17M |
2013 Q2
46 quarters
|
|
|
SII
3273
Sprott
SII
$2.99B
| $4.82M | ﹤0.01% |
114,219
+10,302
| +10% | +$454K |
2020 Q2
18 quarters
|
|
3274
iShares U.S. Large Cap Premium Income Active ETF
BALI
$1.41B
| $4.81M | ﹤0.01% |
+159,065
| New | +$4.89M |
2024 Q4
0 quarters
|
|
3275
Ducommun
DCO
$2.65B
| $4.81M | ﹤0.01% |
75,509
+69,473
| +1,151% | +$4.46M |
2017 Q4
28 quarters
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.